Filing Details
- Accession Number:
- 0001181431-14-021936
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-05-30 17:41:40
- Reporting Period:
- 2014-05-27
- Filing Date:
- 2014-05-30
- Accepted Time:
- 2014-05-30 17:41:40
- Original Submission Date:
- 2014-05-29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053650 | Omega Protein Corp | OME | Fats & Oils (2070) | 760438393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1436243 | P Gregory Toups | 2105 City West Boulevard Suite 500 Houston TX 77042 | Vp Ch Acct Officer & Controlle | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-27 | 5,000 | $7.54 | 35,378 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-05-27 | 5,000 | $14.13 | 30,378 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-05-27 | 5,000 | $0.00 | 5,000 | $7.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,000 | 2007-06-29 | 2016-12-27 | No | 4 | M | Direct |
Footnotes
- This transaction is not new or revised but is being reported again for the sole purpose of gaining access to the EDGAR system.The purpose of filing this amendment to Form 4 dated May 29, 2014 for Gregory Toups ("Original Form 4") is to correct footnote 1 to the Original Form 4. That footnote stated that the 5,000 stock options exercised and the 5,000 shares of Common Stock sold reported in that Original Form 4 were exercised and sold pursuant to an SEC Rule 10b5-1 Trading Plan. Such stock options and shares were in fact not exercised and sold pursuant to a Rule 10b5-1 Trading Plan. All other items in the Original Form 4 remain unchanged and correct.
- Value represents transactions with a weighted average sales price ranging from $14.07 to $14.30.
- Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
- Vests in 1/3 increments commencing on the first anniversary of date of grant.
Billionaire Hedge Funds
